We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Canon to Purchase Toshiba Medical Unit in Deal Worth Nearly USD 6 Billion

By MedImaging International staff writers
Posted on 22 Mar 2016
Toshiba has sold all its shares in Toshiba Medical Systems for USD 5.9 billion (JPY 665.5 billion) to Canon, as part of a major restructuring plan.

The two companies plan to complete the transaction in FY2016, if the deal closes on time and pending clearance of the deal by competition regulatory authorities.

Canon (Tokyo, Japan) won exclusive negotiating rights to purchase the Toshiba medical unit which manufactures modalities such as Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) scanners, after a highly-competitive auction. Canon manufacturers X-ray systems, and will now expand into the high-margin medical device market.

The sale follows a large accounting scandal that has affected Toshiba Medical Systems Corporation (Otawara, Tochigi-ken, Japan). Toshiba revealed details of the scandal in 2015, as part of which Toshiba had overstated profits from around 2009. In a related move Toshiba announced job cuts for more than 10,000 of its staff and also plans to sell other parts of the company. The company is expected to make a loss of about USD 6.0 billion for the year until March 2016, and may receive a JPY 7.37 billion fine from the Japanese Securities and Exchange Surveillance Commission.

Related Links:

Toshiba
Canon


Ultrasound Needle Guidance System
SonoSite L25
Half Apron
Demi
40/80-Slice CT System
uCT 528
Post-Processing Imaging System
DynaCAD Prostate

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.